NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT04175912 2025-11-17Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverNational Cancer Institute (NCI)Phase 2 Active not recruiting40 enrolled 11 charts